UPDATE : Tuesday, July 23, 2019
FDA starts inspecting SK Biopharm’s epilepsy treatment
SK Biopharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Lee Han-soo  |  2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo  |  2019-02-07 14:40
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi  |  2019-02-07 14:40
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo  |  2019-02-07 11:09
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo  |  2019-02-01 17:04
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease
Novartis Korea’s dementia treatment Exelon (rivastigmine) obtained expanded...
by Kim Yun-mi  |  2019-02-01 17:02
‘Alunbrig works better for ALK-positive non-small cell lung cancer’
Second-line treatment options are increasing for patients with anaplastic l...
by Kim Yun-mi  |  2019-02-01 15:38
Medytox, Daewoong continue to squabble over BTX
A heated debate is continuing between Medytox and Daewoong Pharmaceuticals ...
by Lee Han-soo  |  2019-02-01 15:36
Santen Pharma to sell Huonland’s eye drop in China
Huonland said Wednesday that it has signed a memorandum of understanding wi...
by Lee Han-soo  |  2019-02-01 11:56
14 pharmaceuticals to release gastritis generic drugs soon
Fourteen pharmaceutical firms are to roll out generic copies of Stillen 2X ...
by Lee Hye-seon  |  2019-02-01 11:55
AbClon transfers target antibody technology to GC Labcell
GC Labcell said Wednesday that it has signed a 3 billion won ($2.7 million)...
by Lee Han-soo  |  2019-01-31 16:23
Novo Nordisk’s growth hormone injection gets expanded coverage
Novo Nordisk said Wednesday that the Ministry of Health and Welfare would e...
by Lee Han-soo  |  2019-01-31 15:18
‘Pseudoephedrine-containing drugs could cause acute skin reaction’ 
The government is likely to add a warning in the instructions of pseudoephe...
by Lee Hye-seon  |  2019-01-31 14:34
Kwangdong dismisses rumors of terminating sales for Contrav
Kwangdong Pharmaceutical denied Thursday rumors of the company stopping sal...
by Lee Han-soo  |  2019-01-31 14:32
Ipsen’s renal cancer drug Carbometyx gets insurance benefit
Ipsen Korea’s advanced renal cell carcinoma treatment Carbometyx (cabozanti...
by Park Gi-taek  |  2019-01-31 11:13
₩4.7 billion spent on compensation for side effect injuries in 4 years
Korea used 4.74 billion won ($4.24 million) to compensate the damages such ...
by Lee Hye-seon  |  2019-01-30 17:18
Pfizer’s lung cancer drug Xalkori threatened by new rivals
Pfizer’s Xalkori (ingredient: crizotinib) has been solidifying its status a...
by Kim Yun-mi  |  2019-01-30 12:34
Biogen, NHIS begin price talk for spinal muscular atrophy treatment
The National Health Insurance Service (NHIS) and Biogen started price negot...
by Lee Han-soo  |  2019-01-30 11:43
GC to stop making 1st thrombolytic agent amid poor sales
GC will stop manufacturing Urokinase, Korea’s first thrombolytic agent, aft...
by Lee Han-soo  |  2019-01-29 16:44
Sanofi gets nod to increase dosage for multiple sclerosis treatment
Sanofi Genzyme Korea said that the Ministry of Food and Drug safety has exp...
by Lee Han-soo  |  2019-01-28 17:02
Back to Top